Videos

The Human Trial – Vox Pop Films

The Human Trial is an independent, feature-length documentary that is in the works, currently following ViaCyte’s quest to develop what might become a functional cure for type 1 diabetes (T1D).  After working many years towards this important goal, in October 2014 ViaCyte began the first human clinical trial to test a stem cell-derived cell replacement therapy in patients with T1D.  This segment of The Human Trial provides a glimpse into the efforts of the ViaCyte team as we pursue our goal of changing the lives of millions of people living with T1D.

This video is courtesy of Vox Pop Films

2016 Cell and Gene Meeting on the Mesa

President and CEO of ViaCyte, Dr. Paul Laikind, provides an update on ViaCyte’s two product candidates, PEC-Direct and PEC-Encap, which are novel cell replacement therapies being developed as potential long-term type 1 diabetes treatments to reduce the risk of hypoglycemia and diabetes-related complications. This talk was presented at the 2016 Cell and Gene Meeting on the Mesa.

CIRM Movie – Diabetes

What do patients with type 1 diabetes (T1D) want from their treatments?  Freedom.  T1D is a 24-hour-a-day, 7-day-a-week, 365-day-a-year disease.  Taking just a single day off from the responsibilities of self-treatment and blood sugar monitoring can mean hospitalization or even death.  ViaCyte’s new approach to diabetes treatment could offer valuable relief to many patients who struggle with the daily burden of maintaining healthy blood sugar levels.  ViaCyte is working towards recreating the functions of the endocrine pancreas with a self-contained implant of stem cell-derived pancreatic progenitor cells designed to mature and produce insulin and the other hormones needed to naturally regulate glucose levels.  The goal is to give patients and families relief from the constant vigilance required to live with T1D, while at the same time providing a better, more natural solution to disease treatment.

This video is courtesy of the California Institute for Regenerative Medicine (CIRM).

Whiteboard Video – Americans for Cures: Report Back To the Public

Stem cell research and development underway at ViaCyte is seeking to change the way type 1 diabetes (T1D) is treated.  This video explains how our stem cell research and development, funded by California’s Proposition 71: the California Stem Cell Research and Cures Initiative, is leading to potentially groundbreaking advances in treating diabetes.  The video provides an informative and engaging overview on the cause of T1D, the inherent issues with current diabetes treatments, and how ViaCyte’s VC-01TM product candidate is working towards eliminating or reducing daily insulin injections.  The VC-01 product candidate is designed to deliver an entire community of human hormone producing cells – including insulin producing beta cells – that are naturally found in the Islet of Langerhans to patients with T1D.  This community of cells may act similarly to a normal healthy pancreas and could provide effective control of blood glucose levels thus providing a functional cure for the disease.  ViaCyte has received funding and support from the California Institute for Regenerative Medicine (CIRM) and JDRF.

This video was produced as part of the Americans for Cures Foundation’s Report Back to the Public program.  For more information about type 1 diabetes, check out the new Americans for Cures website, and follow Americans for Cures on Facebook and Twitter for live updates. 

Conversations That Matter with Kevin D’Amour, Ph.D.

During the International Diabetes Federation (IDF) Conference in December 2015 in Vancouver, ViaCyte’s VP of Research and CSO, Kevin D’Amour, Ph.D., sat down with interviewer Stu McNish to discuss the cause of type 1 diabetes, and how ViaCyte is working toward creating a functional cure. Dr. D’Amour provides an overview of diabetes, the current unmet medical need, and the development of the VC-01 product candidate as a cell replacement therapy.

This video is provided by Conversations That Matter and was produced by Oh Boy Productions. Other videos from Conversations That Matter can be viewed on the Vancouver Sun’s website.